5-Bromo-N-(tert-butyl)-3-methylpicolinamide

Catalog No.: 
ACTBIJ264
CAS No.: 
156072-91-2
Molecular Formula: 
C11H15BrN2O
Molecular Weight: 
271.16
5-Bromo-N-(tert-butyl)-3-methylpicolinamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$161.00InquiryInquiry
250mg98%$232.00InquiryInquiry
1g98%$563.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-N-(tert-butyl)-3-methylpicolinamide
IUPAC Name5-bromo-N-(tert-butyl)-3-methylpicolinamide
Molecular FormulaC11H15BrN2O
Molecular Weight271.16
SMILESO=C(NC(C)(C)C)C1=NC=C(Br)C=C1C
InChI KeyINGQVFWRUJSCHT-UHFFFAOYSA-N
Synonym5-bromo-N-(tert-butyl)-3-methylpicolinamide;2-Pyridinecarboxamide, 5-bromo-N-(1,1-dimethylethyl)-3-methyl-;5-Bromo-3-methyl-pyridine-2-carboxylic acid tert-butylamide
CAS No.156072-91-2

Synthetic Route by SureRoute

1. ACTBIJ264 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPLCQ651 route compound structure diagram
    ACPLCQ65160469-70-7In Stock
  2. Plus
  3. ACGYFP790 route compound structure diagram
    ACGYFP790886365-43-1In Stock
  4. Then
  5. ACTBIJ264 route product structure diagram
    ACTBIJ264156072-91-2
Inquiry

2. ACTBIJ264 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPLCQ651 route compound structure diagram
    ACPLCQ65160469-70-7In Stock
  2. Plus
  3. ACVJWL362 route compound structure diagram
    ACVJWL362794592-13-5In Stock
  4. Then
  5. ACTBIJ264 route product structure diagram
    ACTBIJ264156072-91-2
Inquiry

3. ACTBIJ264 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPLCQ651 route compound structure diagram
    ACPLCQ65160469-70-7In Stock
  2. Plus
  3. ACDYEL091 route compound structure diagram
    ACDYEL091213771-32-5In Stock
  4. Then
  5. ACTBIJ264 route product structure diagram
    ACTBIJ264156072-91-2
Inquiry

Comments (0)